These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18448798)

  • 1. The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy.
    Lukic IK; Humpert PM; Nawroth PP; Bierhaus A
    Ann N Y Acad Sci; 2008 Apr; 1126():76-80. PubMed ID: 18448798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).
    Haslbeck KM; Schleicher E; Bierhaus A; Nawroth P; Haslbeck M; Neundörfer B; Heuss D
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):288-91. PubMed ID: 15926115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.
    Bierhaus A; Haslbeck KM; Humpert PM; Liliensiek B; Dehmer T; Morcos M; Sayed AA; Andrassy M; Schiekofer S; Schneider JG; Schulz JB; Heuss D; Neundörfer B; Dierl S; Huber J; Tritschler H; Schmidt AM; Schwaninger M; Haering HU; Schleicher E; Kasper M; Stern DM; Arnold B; Nawroth PP
    J Clin Invest; 2004 Dec; 114(12):1741-51. PubMed ID: 15599399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of advanced glycation end products and their receptors in development of diabetic neuropathy.
    Wada R; Yagihashi S
    Ann N Y Acad Sci; 2005 Jun; 1043():598-604. PubMed ID: 16037282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products and diabetic foot disease.
    Huijberts MS; Schaper NC; Schalkwijk CG
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S19-24. PubMed ID: 18442180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A; Beckman JA; Schmidt AM; Creager MA
    Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
    Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
    J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE in inflammation: a new therapeutic target?
    Bierhaus A; Stern DM; Nawroth PP
    Curr Opin Investig Drugs; 2006 Nov; 7(11):985-91. PubMed ID: 17117586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
    Harashima A; Yamamoto Y; Cheng C; Tsuneyama K; Myint KM; Takeuchi A; Yoshimura K; Li H; Watanabe T; Takasawa S; Okamoto H; Yonekura H; Yamamoto H
    Biochem J; 2006 May; 396(1):109-15. PubMed ID: 16503878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy.
    Haslbeck KM; Bierhaus A; Erwin S; Kirchner A; Nawroth P; Schlötzer U; Neundörfer B; Heuss D
    Muscle Nerve; 2004 Jun; 29(6):853-60. PubMed ID: 15170618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
    Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
    Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of grape seed proanthocyanidin extracts downregulate RAGE dependant nuclear factor- kappa BP65 expression in the hippocampus of streptozotocin induced diabetic rats.
    Xu L; Li B; Cheng M; Zhang W; Pan J; Zhang C; Gao H
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):215-24. PubMed ID: 18273752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth.
    Wang L; Li S; Jungalwala FB
    J Neurosci Res; 2008 May; 86(6):1254-66. PubMed ID: 18058943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease.
    Maczurek A; Shanmugam K; Münch G
    Ann N Y Acad Sci; 2008 Apr; 1126():147-51. PubMed ID: 18448809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.
    Myint KM; Yamamoto Y; Doi T; Kato I; Harashima A; Yonekura H; Watanabe T; Shinohara H; Takeuchi M; Tsuneyama K; Hashimoto N; Asano M; Takasawa S; Okamoto H; Yamamoto H
    Diabetes; 2006 Sep; 55(9):2510-22. PubMed ID: 16936199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
    Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
    Yan SF; Ramasamy R; Schmidt AM
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
    Nishizawa Y; Koyama H
    J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end product receptor-mediated cellular dysfunction.
    Bierhaus A; Humpert PM; Stern DM; Arnold B; Nawroth PP
    Ann N Y Acad Sci; 2005 Jun; 1043():676-80. PubMed ID: 16037292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.